| COMPOSITION: | Each film coated tablet contains Empagliflozin 25 mg |
| FORMULATION: | TABLET |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Empiford tablets contains Empagliflozin, a medication primarily used to manage type 2 diabetes by inhibiting the sodium-glucose co-transporter 2 (SGLT2). This helps reduce blood glucose levels by promoting the excretion of excess glucose through urine, while also offering cardiovascular and kidney protection benefits. |
| SIDE EFFECTS: | Common side effects include urinary tract infections, increased urination, dehydration, low blood pressure, and an increased risk of genital infections. Rarely, it may cause ketoacidosis or kidney problems. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
